Tiazac and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Tiazac (diltiazem hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Zometa, and have Metastases to spine.

The phase IV clinical study analyzes which people have Swelling when taking Tiazac. It is created by eHealthMe based on reports of 4,624 people who have side effects when taking Tiazac from the FDA, and is updated regularly.

What is Tiazac?

Tiazac has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 4,761 Tiazac users. Check the latest studies of Tiazac.

What is Swelling?

Swelling is found to be associated with 2,296 drugs and 2,894 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 12, 2026

4,624 people reported to have side effects when taking Tiazac.
Among them, 74 people (1.6%) have Swelling.

Among these 74 people:

How long have people been on Tiazac when they have Swelling? *

What is the gender of people who have Swelling when taking Tiazac? *

female: 56.34 %
male: 43.66 %

What is the age of people who have Swelling when taking Tiazac? *

What are other drugs people take besides Tiazac? *

What are other side effects people have besides Swelling? *

Pain: 49 people, 66.22%
Stress And Anxiety: 45 people, 60.81%
Bone Disorder: 43 people, 58.11%
Infection: 43 people, 58.11%
Dyspnea (difficult or laboured breathing): 39 people, 52.70%
Injury: 38 people, 51.35%
Weakness: 37 people, 50.00%
Tooth Loss: 37 people, 50.00%
Pneumonia: 37 people, 50.00%
Joint Pain: 36 people, 48.65%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 26 people, 35.14%
Calcium Deficiency (lack of calcium): 26 people, 35.14%
Metastases To Spine (cancer spreads to spine): 26 people, 35.14%
Lung Neoplasm (tumour of lung): 25 people, 33.78%
Metastases To Bone (cancer spreads to bone): 12 people, 16.22%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 13.51%
High Blood Cholesterol: 7 people, 9.46%
Multiple Myeloma (cancer of the plasma cells): 6 people, 8.11%
Pain: 6 people, 8.11%
Carcinoid Tumor: 6 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Tiazac and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tiazac:

Tiazac (4,761 reports)

Swelling treatments and more:

Swelling (115,742 reports)

Browse all side effects of Tiazac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,296 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,894 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Tiazac) and Tiazac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.